, Health and Social Care Committee
Gynaecological cancers: Panel 8
Joyce.
, Health and Social Care Committee
Gynaecological cancers: Panel 8
The dashboard that we can't see.
, Health and Social Care Committee
Gynaecological cancers: Panel 8
Absolutely. I think that's come out through the evidence session and quite powerfully as well, so thank you. Gareth, sorry, did you want to come in?
, Health and Social Care Committee
Gynaecological cancers: Panel 8
Jo, if you want to come in on the question before as well, by all means make a start on that.
, Health and Social Care Committee
Gynaecological cancers: Panel 8
We're all working. Yes, it is.
, Health and Social Care Committee
Gynaecological cancers: Panel 8
There we are. Thank you. Mabon ap Gwynfor.
, Health and Social Care Committee
Gynaecological cancers: Panel 8
What's the appropriate phrase to use?
, Health and Social Care Committee
Gynaecological cancers: Panel 8
Thank you. Joyce, I think it is. Joyce Watson. Am I right?
, Health and Social Care Committee
Gynaecological cancers: Panel 8
There we are. Lovely. Thank you, Jo. Gareth.
, Health and Social Care Committee
Gynaecological cancers: Panel 8
Sorry, Gareth. Jo, could you just do a translation check? We'll just make sure it's working. [TRANSLATION: 'This is the translator speaking. You should be able to hear me now. Okay, great, thank you.']
, Health and Social Care Committee
Gynaecological cancers: Panel 8
Oh, I'm sorry—
, Health and Social Care Committee
Gynaecological cancers: Panel 8
Thank you, Sarah. Gareth Davies.
, Health and Social Care Committee
Gynaecological cancers: Panel 8
That's a clear answer, yes, thank you. We'll explore that, separately. Thank you. Sarah Murphy.
, Health and Social Care Committee
Gynaecological cancers: Panel 8
Thank you. Should the dashboard be publicly available, do you think?
, Health and Social Care Committee
Gynaecological cancers: Panel 8
Okay. Thank you. Members will probably dive in to a lot of what you've said in your opening comments, so thank you. Joyce Watson.
, Health and Social Care Committee
Gynaecological cancers: Panel 8
So, you don't think there is enough planning to do that.
, Health and Social Care Committee
Gynaecological cancers: Panel 8
And how confident are you that sufficient capacity and planning in health and social care is going to meet future demand?
, Health and Social Care Committee
Gynaecological cancers: Panel 8
I notice in your paper on that you said that women are less likely to want to die at home. Can you just perhaps expand on that a bit more?
, Health and Social Care Committee
Gynaecological cancers: Panel 8
In Wales.
, Health and Social Care Committee
Gynaecological cancers: Panel 8
Lovely. Thanks ever so much for being with us today and for your advanced correspondence with us, as well. We've had some very powerful evidence to committee. I'm not sure whether you've had the chance to see some of our earlier sessions, but some were very…
, Health and Social Care Committee
Gynaecological cancers: Panel 8
Croeso, bawb. Welcome back to the Health and Social Care Committee. I move to item 3, and this is the eighth evidence session of the committee's inquiry into gynaecological cancers. In this session, we'll be hearing from representatives from Marie Curie. I'd…
, Health and Social Care Committee
Gynaecological cancers: Panel 7
With that, we'll take a 10-minute break. We'll be back just before 10:45.
, Health and Social Care Committee
Gynaecological cancers: Panel 7
That's interesting; that's helpful. Professor Dyfed and Helen Thomas, can I thank you both for your time with us this morning? It's been a really helpful and useful session. We'll send you a copy of the transcript, but if there's anything else you think you…
, Health and Social Care Committee
Gynaecological cancers: Panel 7
That's very helpful to appreciate, the adaption and development of the Welsh NHS app. I can see it will impact things considerably, yes. Thank you, Helen. Dyfed, any last comment from you at all, or anything you believe that would help our work?
, Health and Social Care Committee
Gynaecological cancers: Panel 7
That's good to hear. Thank you, Dyfed. And, Helen, I'll just come to you for my last question I put to you earlier. Is there anything else that you want to impart to us that you think will help our work at all that's not been drawn out through questions today?
